Lv2
180 积分 2023-05-12 加入
High-dose Furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A prospective real-world study
3小时前
待确认
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
29天前
已完结
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
1个月前
已完结
Correlation of HER-2/Neu Protein Expression and HER2 Gene Amplification with Clinical Morphological Parameters of Nonsmall Cell Lung Cancer
1个月前
已完结
ERBB2 Amplification in NSCLC: How Many Faces?
1个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
1个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
2个月前
已完结
Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment
2个月前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
2个月前
已完结
Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review
2个月前
已完结
皖公网安备34019202002308
